Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: Association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases

European Journal of Immunology

Volumn 28, Issue 1, 1998, Pages 264-276

  Le Dréan, Eric ^b   Vély, Frédéric ^a   Olcese, Lucia ^a   Cambiaggi, Anna ^a   Guia, Sophie ^a   Krystal, Gerald ^c   Gervois, Nadine ^b   Moretta, Alessandro ^d   Jotereau, Francine ^b   Vivier, Eric ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSTITUT DE BIOLOGIE   (France)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Immunoreceptor tyrosine based inhibition motif; Killer cell inhibitory receptor; Melanoma antigen; Phosphatase; Tumor immunology

Indexed keywords

CD16 ANTIGEN; CD94 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN TYROSINE PHOSPHATASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DISSOCIATION CONSTANT; LYMPHOCYTE CLONE; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; ANTIGENS, CD94; DIMERIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; KINETICS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MACROMOLECULAR SUBSTANCES; MELANOMA; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS; SHP1 PROTEIN TYROSINE PHOSPHATASE; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2642611958     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O     Document Type: Article

References (58)

1. Cyster, J. G. and Goodnow, C. C., Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity 1997. 6: 509-517.
2. Renard, V., Cambiaggi, A., Vély, F., Blery, M., Olcese, L., Olivero, S., Bouchet, M. and Vivier, E., Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol. Rev. 1997. 155: 205-221.
3. Weiss, A. and Littman, D. R., Signal transduction by lymphocyte antigen receptors. Cell 1994. 76: 263-274.
4. Ravetch, J. V. and Kinet, J.-P., Fc receptors. Annu. Rev. Immunol. 1991. 9: 457-492.
5. Reth, M., Antigen receptor tail clue. Nature 1989. 338: 383-384.
6. Malissen, B. and Schmitt-Verhulst, A.-M., Transmembrane signalling through the T-cell-receptor-CD3-complex. Curr. Opin. Immunol. 1993. 5: 324-333.
7. Amigorena, S., Bonnerot, C., Drake, J., Choquet, D., Hunziker, W., Guillet, J.-G., Webster, P., Sautès, C., Mellman, I. and Fridman, W. H., Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B-lymphocytes. Science 1992. 256: 1808-1812.
8. Muta, T., Kurosaki, T., Misulovin, Z., Sanchez, M., Nussenzweig, M. C. and Ravetch, J. V., A 13-amino-acid motif in the cytoplasmic domain of FcγRIIb modulates B-cell receptor signaling. Nature 1994. 368: 70-73.
9. Cambier, J. C., Inhibitory receptors abound? Proc. Natl. Acad. Sci. USA 1997. 94: 5993-5995.
10. Vivier, E. and Daëron, M., Immunoreceptor Tyrosine-based Inhibition Motifs (ITIMs). Immunol. Today 1997. 18:286-291.
11. Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajogopalan, S., Berrada, K., Yi, T., Kinet, J.-P. and Long, E. O., Recruitment of tyrosine phosphatase HCP by the killer inhibitory receptor. Immunity 1996. 4: 77-85.
12. Gumprez, J. E. and Parham, P., The enigma of the natural killer cell. Nature 1995. 378: 245-248.
13. Leibson, P. J., Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 1997. 6: 655-661.
14. Raulet, D. H., Held, W., Correa, I., Dorfman, J. R., Wu, M. F. and Corral, L., Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 1997. 155: 41-52.
15. Lanier, L. L., Natural killer cells: from no receptors to too many. Immunity 1997. 6: 371-378.
16. Olcese, L., Lang, P., Vély, F., Cambiaggi, A., Marguet, D., Blery, M., Hippen, K. L., Biassoni, R., Moretta, A., Moretta, L., Cambier, J. C. and Vivier, E., Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 1996. 156: 4531-4534.
17. Campbell, K. S., Dessing, M., Lopez-Botet, M., Cella, M. and Colonna, M., Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 1996. 184: 93-100.
18. Fry, A. M., Lanier, L. L. and Weiss, A., Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J. Exp. Med. 1996. 184: 295-300.
19. Binstadt, B. A., Brumbaugh, K. M., Dick, C. J., Scharenberg, A. M., Williams, B. L., Colonna, M., Lanier, L. L., Kinet, J.-P., Abraham, R. T. and Leibson, P. J., Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 1996. 5: 629-638.
20. Nakamura, M. C., Niemi, E. C., Fisher, M. J., Shultz, L. D., Seaman, W. E. and Ryan, J. C., Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J. Exp. Med, 1997. 185: 673-684.
21. Phillips, J. H., Chang, C., Mattson, J., Gumprez, J. E., Parham, P. and Lanier, L. L., CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 1996. 5: 163-172.
22. Houchins, J. P., Lanier, L. L., Niemi, E. C., Phillips, J. H. and Ryan, J. C., Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 1997. 158: 3603-3609.
23. Brooks, A. G., Posch, P. E., Scorzelli, C. J., Borrego, F. and Coligan, J. E., NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 1997. 185: 795-800.
24. Sivori, S., Vitale, M., Bottino, C., Marcenaro, E., Sanseverino, L., Parolini, S., Moretta, L. and Moretta, A., CD94 functions as a natural killer cell inhibitory receptor for HLA class I allele: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 1996. 26: 2487-2492.
25. Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L. and Phillips, J. H., Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996. 157: 4741-4745.
26. Carretero, M., Cantoni, C., Bellon, T., Bottino, C., Biassoni, R., Rodriguez, A., Pérez-Vilar, J. J., Moretta, L., Moretta, A. and Lopez-Botet, M., The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 1997. 27: 563-567.
27. Mingari, M. C., Vitale, C., Cambiaggi, A., Schiavetti, F., Melioli, G., Ferrini, S. and Poggi, A., Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 1995. 7: 697-703.
28. Ideka, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T. and Coulie, P. G., Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 1997. 6: 199-208.
29. Bléry, M., Delon, J., Trautmann, A., Cambiaggi, A., Olcese, L., Biassoni, R., Moretta, L., Chavrier, P., Moretta, A., Daëron, M. and Vivier, E., Reconstituted killer-cell inhibitory receptors for MHC Class I molecules control mast cell activation induced by immunoreceptor tyrosine-based activation motifs. J. Biol. Chem. 1997. 272: 8989-8996.
30. Chang, C., Rodriguez, A., Carretero, M., Lopez-Botet, M., Philips, J. H. and Lanier, L. L., Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 1995. 25: 2433-2437.
31. Houchins, J. P., Yabe, T., McSherry, C. and Bach, F. H., DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 1991. 173: 1017-1020.
32. Ono, M., Bolland, S., Tempst, P. and Ravetch, J. V., Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 1996. 383: 263-266.
33. Vély, F., Olivero, S., Olcese, L., Moretta, A., Damen, J. E., Liu, L., Krystal, G., Cambier, J. C., Daëron, M. and Vivier, E., Differential association of phosphatases with hematopoietic co-receptors bearing immunoreceptor tyrosine-based inhibition motifs. Eur. J. Immunol. 1997. 27: 1994-2000.
34. Secrist, J. P., Burns, L. A., Karnitz, L., Koretsky, G. A. and Abraham, R. T., Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem. 1993. 268: 5886-5893.
35. Aramburu, J., Balboa, M. A., Ramirez, A., Silva, A., Acevedo, F., Sanchez-Madrid, F., De Landàzuri, M. O. and Lòpez-Botet, M., A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-γ/δ+ lymphocytes. I. Inhibition of the IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J. Immunol. 1990. 144: 3228-3233.
36. Lanier, L. L., Corliss, B. and Phillips, J. H., Arousal and inhibition of human NK cells. Immunol. Rev. 1997. 155: 145-154.
37. Mingari, M. C., Vitale, C., Cantoni, C., Bellomo, R., Ponte, M., Schiavetti, F., Bertone, S., Moretta, A. and Moretta, L., Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 1997. 27: 1374-1380.
38. Boon, T., Coulie, P. G. and Van den Eyden, B., Tumor antigens recognized by T cells. Immunol. Today 1997. 18: 267-268.
39. Mingari, M. C., Schiavetti, F., Ponte, M., Vitale, C., Maggi, E., Romagnani, S., Demarest, J., Pantaleo, G., Fauci, A. S. and Moretta, L., Human CD8+ T lymphocytes subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 1996. 93: 12433-12438.
40. Fitzegerald, J. E., Ricalton, N. S., Meyer, A. C., West, S. G., Kaplan, H., Behrendt, C. and Kotzin, B. L., Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J. Immunol. 1995. 154: 3538-3547.
41. Unkeless, J. C. and Jie, J., Inhibitory receptors, ITIM sequences and phosphatases. Curr. Opin. Immun. 1997. 9: 338-343.
42. D'Ambrosio, D., Hippen, K. L., Minskoff, S. A., Mellman, I., Pani, G., Siminovitch, K. A. and Cambier, J. C., Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1. Science 1995. 268: 293-296.
43. Scharenberg, A. M., Lin, S., Cuenod, B., Yamamura, H. and Kinet, J.-P., Reconstitution of interactions between tyrosine kinases and the high affinity IgE receptor which are controlled by receptor clustering. EMBO. J. 1995.14: 3385-3394.
44. Fong, D. C., Malbec, O., Arock, M., Cambier, J. C., Fridman, W. H. and Daëron, M., Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated FcγRIIB during negative regulation of IgE-dependent mast cell activation. Immunol. Lett. 1996. 54: 83-91.
45. Doody, G. M., Justement, L. B., Delibrias, C. C., Matthews, R. J., Lin, J., Thomas, M. L. and Fearon, D. T., A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995. 269: 242-244.
46. Eck, M. J., Pluskey, S., Trüb, T., Harrison, S. C. and Shoelson, S. E., Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature 1996. 379: 277-280.
47. Pluskey, S., Wandless, T. J., Walsh, C. T. and Shoelson, S. E., Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J. Biol. Chem. 1995. 270: 2897-2900.
48. Valiante, N. M., Phillips, J. H., Lanier, L. L. and Parham, P., Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-γ signalling complex in human NK cells. J. Exp. Med. 1996. 184: 2243-2250.
49. Neel, B. G. and Tonks, N. K., Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol. 1997. 9: 193-204.
50. Marengère, L. E. M., Waterhouse, P., Duncan, G. S., Mittrücker, H.-W., Feng, G.-S. and Mak, T. W., Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 1996. 272: 1170-1173.
51. Daëron, M., Latour, S., Malbec, O., Espinosa, E., Pina, P., Pasmans, S. and Fridman, W. H., The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-independent cell activation. Immunity 1995. 3: 635-646.
52. Daëron, M., Malbec, O., Latour, S., Arock, M. and Fridman, W. H., Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J. Clin. Invest. 1995. 95: 577-585.
53. Damen, J. E.. Liu, L., Rosten, P., Humphries, R. K., Jefferson, A. B., Majerus, P. W. and Krystal, G., The 145-kDa protein induced to associate with She by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc. Natl. Acad. Sci. USA 1996. 93: 1689-1693.
54. Pérez-Villar, J. J., Carretero, M., Navarro, F., Malero, I., Rodrìguez, A., Bottino, C., Moretta, A. and Lòpez-Botet, M., Biochemical and serological evidence for the existence of functionally distinct isoforms of the CD94 NK-cell receptor. J. Immunol. 1996. 157: 5367-5374.
55. Robertson, M. J., Cochran, K. J., Cameron, C., Le, J. M., Tantravathi, R. and Ritz, J., Characterization of a cell line, NKL, derived from an agressive human natural killer cell leukemia. Exp. Hematol. 1996. 24: 406-415.
56. Pandolfino, M. C., Viret, C., Gervois, N., Guilloux, Y., Davodeau, F., Diez, E. and Jotereau, F., Specificity, T cell receptor diversity and activation requirement of CD4+ and CD8+ T cells derived from human melanoma-infiltrating lymphocytes. Eur. J. Immunol. 1992. 22: 1795-1802.
57. Lang, F., Peyrat, M. A., Constant, P., Davodeau, F., David-Ameline, J., Poquet, Y., Vié, H., Fournié, J.-J. and Bonneville, M., Early activation of human Vγ9Vδ2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J. Immunol. 1995. 154: 5986-5992.
58. Guilloux, Y., Viret, C., Gervois, N., Le Dréan, E., Pandoffino, M. C., Diez, E. and Jotereau, F., Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro. Eur. J. Immunol. 1994. 24: 1966-1973.